Clinical Trial Results: A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for TOUR006 in patients with chronic kidney disease and elevated hs-CRP have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Insufficiency

Drugs mentioned

• TOUR006

Snippet

Sponsor: Tourmaline Bio, Inc., a Novartis Company | Conditions: Chronic Kidney Diseases, Chronic Kidney Insufficiency | Phase 2 | Status: COMPLETED | Results posted: 2026-08-11